NFL clears Eagles in Jalen Hurts blood clot handling — SkimNews
Get the Sports newsletter
Daily sports — scores, transfers, the storylines from the leagues you actually follow. Free.
- Philadelphia Eagles announced Jalen Hurts will miss the rest of the 2026 season after blood clots were found in both lungs, updating his diagnosis from a superficial to deep vein thrombosis with bilateral pulmonary emboli.
- NFL concluded the Eagles appropriately handled Hurts' medical evaluation and clearance to play in Week 5, declining to impose any punishment on the franchise for its process or lack of injury designation.
- Jalen Hurts was cleared to play against the Jacksonville Jaguars in London despite a superficial calf clot, later revealed to have moved, prompting scrutiny over travel and game participation decisions.
- The Athletic reported Hurts was not instructed to stay awake in London due to his condition, countering earlier claims, and confirmed he slept at the hotel and took a nap before kickoff.
- Nicole Lynn and the Eagles issued a joint statement confirming Hurts is clinically stable, expected to fully recover with anticoagulation treatment, and will remain active with the team during recovery.
Why it matters: The NFL’s decision not to penalize the Eagles sets a precedent for how teams manage player health disclosures under league oversight, particularly when medical conditions evolve rapidly. With Hurts out for the season, the team’s playoff viability weakens while scrutiny grows over whether early transparency could have altered outcomes.
Ask SkimNews
